racemetirosine has been researched along with Brain Injuries, Traumatic in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Brain Injuries, Traumatic: A form of acquired brain injury which occurs when a sudden trauma causes damage to the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woodman, R | 1 |
| Miller, C | 1 |
| Student, J | 1 |
| Freeman, K | 1 |
| Perl, D | 1 |
| Lockette, W | 1 |
1 other study available for racemetirosine and Brain Injuries, Traumatic
| Article | Year |
|---|---|
Alpha-methyltyrosine reduces the acute cardiovascular and behavioral sequelae in a murine model of traumatic brain injury.
Topics: alpha-Methyltyrosine; Animals; Bicarbonates; Brain Injuries, Traumatic; Catecholamines; Chlorides; D | 2023 |